Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study
Jin‐Hu Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongyuan Li(The Affiliated Yongchuan Hospital of Chongqing Medical University), Min Yan(Zhengzhou University), Zongbi Yi(Wuhan University), Jiayu Wang(Nanjing University of Chinese Medicine), Xue-Nong Ouyang, Huawei Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Cai(Wenzhou Medical University), Tao Sun(Liaoning Cancer Hospital & Institute), Huan Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianjun He(Sun Yat-sen University), Xinlan Liu(Yunnan Agricultural University), Zefei Jiang, Xichun Hu(Fudan University Shanghai Cancer Center), Zhongsheng Tong(Institute of Oncology NN Petrov), Yang Shun-e(Xinjiang Medical University), Shusen Wang(Sun Yat-sen University), Su Zhang(Southern University of Science and Technology), Xiaojia Wang(Wenzhou Medical University), Yongmei Yin(Jiangsu Cancer Hospital), Runxiang Yang(Kunming Medical University), Tao Huang(Union Hospital), Yuee Teng(First Hospital of China Medical University), Hui Li(University of Electronic Science and Technology of China), Quchang Ouyang(Hunan Cancer Hospital), Binghe Xu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 32
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k